Condition: BRCA1 Mutation · BRCA2 Mutation · Sponsor: Duke University
The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).
This description comes directly from the study's public registry record.
Amelia Scott · (919) 613-4584 · amelia.lorenzo@duke.edu
Always discuss trial participation with your own doctor first.
| UNC Chapel Hill Health System | Chapel Hill, North Carolina, United States | Recruiting |
| Duke University Health System | Durham, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06972719